Aquestive Therapeutics (AQST) Competitor Comparison
We are evaluating the key criteria listed to compare Aquestive Therapeutics (AQST) against its competitors in the Biotechnology industry.
Market Capitalization
220 / 368Gross Profits
74 / 278Total Revenue
126 / 300EBITDA
87 / 337Free Cashflow
116 / 352Quick Ratio
314 / 357Earnings per Share
78 / 359Dividend yield
0 / 6Total Cash
293 / 358Performance 3 years
100 / 368Performance 5 years
133 / 368Performance 10 years
175 / 368Linearity 3 years
39 / 368Linearity 5 years
56 / 368Linearity 10 years
205 / 368Total Rank
135 / 368Dividend Rank
354 / 368Valuation Rank
80 / 368Piotroski Rank
179 / 368Muliplier Rank
34 / 368Piotroski Rank - AQST ranking 179 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.